DOH Logo linking to the DOH Home Page

Notifiable Conditions logo

Blue Line Image
You are here: DOH Home » Notifiable Conditions » Haemophilus influenzae Index Search | Employees
 Site Directory:    Notifiable Conditions: Haemophilus influenzae
Other links concerning Notifiable Conditions
Posters
Associated Programs

PDF documents require the free Acrobat Reader. Click here to download a copy.

Access Washington Logo linking to Access Washington Home Page

     

Haemophilus influenzae (Invasive Disease, Under Age 5 Years)


Cause: Bacterium Haemophilus influenzae. Invasive disease due to any of the 6 capsular types, including type b (Hib) in a child under 5 years of age, is reportable.

Illness and treatment: Invasive syndromes can include meningitis, bacteremia, epiglottitis, pneumonia, or bone and joint infections. Symptoms of meningitis include fever, headache, stiff neck, vomiting, light sensitivity and confusion. About 10% of cases surviving H. influenzae meningitis have permanent neurological damage. Treatment is with antibiotics.

Sources: Humans, including asymptomatic carriers, are the reservoir and transmit through respiratory droplets or direct contact.

Additional risks: Unimmunized or underimmunized infants and children are at risk, especially when they are taken into crowded settings.

Prevention: Immunization of all infants prevents H. influenzae type b infection. Respiratory and hand hygiene prevent transmission.

Recent Washington trends: 4 to 13 cases (due to all serotypes) are reported annually.

2010: Ten cases in children under 5 years were reported with one death. Serotyping results were: serotype a – 1 case; serotype f – 2 cases; and the remaining 7 cases were untypable. Nine of the 10 cases were hospitalized, with 6 requiring admission to an intensive care unit.

Purpose of Reporting and Surveillance

  • To correctly identify the serotype of invasive Haemophilus influenzae (HI) organisms in children under 5 years old.
  • To monitor the effectiveness of immunization programs and vaccines and to assess progress toward elimination of pediatric H. influenzae serotype B (Hib) invasive disease
  • To identify children exposed to Hib cases and closely observe them for signs of illness
  • To recommend antibiotic prophylaxis and/or immunization to appropriate contacts of Hib cases
  • To identify additional cases and establish risk factors for cases of non-Hib invasive H. influenzae disease.

Legal Reporting Requirements

  • Health care providers: immediately notifiable to local health jurisdiction; only cases under 5 years old are reportable
  • Health care facilities: immediately notifiable to local health jurisdiction; only cases under 5 years old are reportable
  • Laboratories: immediately notifiable to local health jurisdiction; only cases under 5 years old are reportable; specimen submission is required — culture, from sterile sites only, when type is unknown (2 business days)
  • Local health jurisdictions: notifiable to the Washington State Department of Health (DOH) Communicable Disease Epidemiology (CDE) within 7 days of case investigation completion or summary information required within 21 days.

Last update
December 2011

Haemophilus influenzae Resources

General Information

Case Definition
(PDF Format)
Haemophilus influenzae Incidence Rates
(PDF Format)

Reporting Forms

Haemophilus influenzae Reporting Form
(PDF Format)

Public Health and Health Care

Surveillance and Reporting Guidelines
(PDF Format)

DOH Home | Access Washington | Privacy Notice | Disclaimer/Copyright Information

Washington State Department of Health
Communicable Disease Epidemiology
MS: K17-9, 1610 NE 150th Street
Shoreline, WA 98155

Consultation and technical assistance are available to local health jurisdictions in Washington State:
Phone (206) 418-5500

FAX (206) 418-5515

24-hour contact (inside Washington State only)  1-877-539-4344

Washington residents can contact their local health jurisdictions for assistance


Send inquires about DOH and its programs to the Health Consumer Assistance Office
Comments or questions regarding this Fact Sheet? Send us an e-mail.